Emerald Advisers’s MacroGenics MGNX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q4 | – | Sell |
-445,295
| Closed | -$8.23M | – | 258 |
|
2017
Q3 | $8.23M | Sell |
445,295
-9,050
| -2% | -$167K | 0.33% | 105 |
|
2017
Q2 | $7.96M | Sell |
454,345
-22,915
| -5% | -$401K | 0.33% | 99 |
|
2017
Q1 | $8.88M | Sell |
477,260
-5,575
| -1% | -$104K | 0.36% | 100 |
|
2016
Q4 | $9.87M | Buy |
482,835
+72,893
| +18% | +$1.49M | 0.42% | 89 |
|
2016
Q3 | $12.3M | Buy |
409,942
+48,799
| +14% | +$1.46M | 0.55% | 73 |
|
2016
Q2 | $9.75M | Sell |
361,143
-151,753
| -30% | -$4.1M | 0.47% | 77 |
|
2016
Q1 | $9.62M | Buy |
512,896
+69,940
| +16% | +$1.31M | 0.47% | 71 |
|
2015
Q4 | $13.7M | Buy |
442,956
+64,698
| +17% | +$2M | 0.65% | 56 |
|
2015
Q3 | $8.1M | Sell |
378,258
-2,601
| -0.7% | -$55.7K | 0.42% | 79 |
|
2015
Q2 | $14.5M | Buy |
380,859
+1,890
| +0.5% | +$71.8K | 0.69% | 46 |
|
2015
Q1 | $12.1M | Buy |
378,969
+3,740
| +1% | +$120K | 0.61% | 51 |
|
2014
Q4 | $13.2M | Buy |
375,229
+143,050
| +62% | +$5.02M | 0.7% | 39 |
|
2014
Q3 | $4.85M | Buy |
232,179
+2,800
| +1% | +$58.5K | 0.29% | 118 |
|
2014
Q2 | $4.98M | Buy |
229,379
+2,460
| +1% | +$53.5K | 0.28% | 125 |
|
2014
Q1 | $6.32M | Buy |
226,919
+17,490
| +8% | +$487K | 0.36% | 103 |
|
2013
Q4 | $5.75M | Buy |
+209,429
| New | +$5.75M | 0.31% | 112 |
|